J. Prous
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Cholinesterase and Neurodegenerative Diseases
-
- Diabetes Treatment and Management
Papers in
-
- Receptor Mechanisms and Signaling 2
- Peroxisome Proliferator-Activated Receptors 2
- Ion channel regulation and function 2
-
- Cholinesterase and Neurodegenerative Diseases 2
- Co-authors
- J. Silvestre (4 shared papers)X Rabasseda (2 shared papers)M. Bayés (2 shared papers)J. Castañer (11 shared papers)M.A. Moral (1 shared paper)Peter Revill (1 shared paper)Nakissa Sadrieh (1 shared paper)Luis G. Valerio (1 shared paper)
- Journals
- Drugs of the Future (12 papers)Drugs of today (1 paper)Journal of Psychopharmacology (1 paper)Drug News & Perspectives (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- SpainUnited States
In The Last Decade
J. Prous
27 papers receiving 662 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 63
- Pharmacology 91
- Endocrinology, Diabetes and Metabolism 84
- Psychiatry and Mental health 62
- Computational Theory and Mathematics 75
Countries citing papers authored by J. Prous
This map shows the geographic impact of J. Prous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Prous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Prous more than expected).
Fields of papers citing papers by J. Prous
This network shows the impact of papers produced by J. Prous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Prous. The network helps show where J. Prous may publish in the future.
Co-authors
The 24 scholars most cited alongside J. Prous, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gateways to clinical trials. | 2004 | 177 |
| 2 | 2002 | 137 | |
| 3 | 2005 | 113 | |
| 4 | Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. | 2000 | 56 |
| 5 | 2013 | 31 | |
| 6 | 2007 | 28 | |
| 7 | 2005 | 27 | |
| 8 | 2006 | 24 | |
| 9 | 2002 | 19 | |
| 10 | 1990 | 19 | |
| 11 | Gateways to clinical trials. March 2003. | 2003 | 15 |
| 12 | 2013 | 11 | |
| 13 | 2001 | 10 | |
| 14 | The year's new drugs and biologics--2007. | 2008 | 9 |
| 15 | The year's new drugs and biologics--2006. | 2007 | 7 |
| 16 | The story so far in R&D. | 2007 | 6 |
| 17 | 1990 | 4 | |
| 18 | 1988 | 3 | |
| 19 | 1998 | 2 | |
| 20 | 1992 | 2 |
About J. Prous
J. Prous is a scholar working on Molecular Biology, Pharmacology, Surgery, Oncology and Cardiology and Cardiovascular Medicine, having authored 28 papers that have together received 711 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Cancer Treatment and Pharmacology (2 papers), Computational Drug Discovery Methods (2 papers), Receptor Mechanisms and Signaling (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Ion channel regulation and function (2 papers). The work is most often cited by research in Pharmacology (63 citations), Pharmacology (91 citations), Endocrinology, Diabetes and Metabolism (84 citations), Psychiatry and Mental health (62 citations) and Computational Theory and Mathematics (75 citations). J. Prous has collaborated with scholars based in Spain and United States. Frequent co-authors include J. Silvestre, X Rabasseda, M. Bayés, J. Castañer, M.A. Moral, Peter Revill, Nakissa Sadrieh, Luis G. Valerio, Courtland Robinson and Siân Davies. Their work appears in journals such as Drugs of the Future, Drugs of today, Journal of Psychopharmacology, Drug News & Perspectives and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.